Journal of Neurology Neurosurgery & PsychiatryVeldsman, M.; Curwood, E.; Pathak, S.; Werden, E.; Brodtmann, A. Default mode network neurodegeneration reveals the remote effects of ischaemic stroke. J. Neurol. Neurosurg. Psychiatry 2017. [CrossRef] [PubMed]...
For the first time, we reviewed the neuroprotective effects of coenzyme Q10 in ischemic stroke. Coenzyme Q10 exerts neuroprotective effects after ischemic stroke through anti-oxidative stress, anti-nitrosative stress, anti-inflammation, and anti-cell death. Here, we provided the evidence on the therap...
Stroke is a leading cause of death and the most common cause of long-term disability in the USA. Women have a lower incidence of stroke compared with men t
Ticagrelor is a direct acting and reversibly binding P2Y12 antagonist approved for the prevention of thromboembolic events. Its potential benefits in ischemic stroke have not been investigated sufficiently. Mice were subjected to 2 hours of transient
book reviews thrombolytic therapy for stroke Clinical trials in the 1990s of intravenous thrombolysis for ischaemic stroke have involved over 3000 patients. Alteplase given within 3 hours of onset sig... Patrick D Lyden,Ed - Humana Press 被引量: 9发表: 2001年 加载更多来源...
SummaryBackground Alteplase is effective for treatment of acute ischaemic stroke but debate continues about its use after longer times since stroke onset, in older patients, and among patients who have had the least or most severe strokes. We assessed the role of these factors in affecting good ...
CAST (Chinese Acute Stroke Trial) Collaborative Group. CAST: randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. Lancet. 1997;349(9066):1641-1649.PubMedGoogle ScholarCrossref 21. Wilcoxon F. Individual comparisons by ranking methods. Biomed ...
Ischemic heart disease (IHD) is a leading cause of death in cardiovascular patients. In China, the disease burden of IHD deaths has significantly increased. One of the main influencing factors of IHD is changing climates, and temperature and diurnal temperature range (DTR) are important indicators...
In acute ischemic stroke, the only FDA-approved drug; recombinant tissue plasminogen activator (rt-PA) is limited by restricted time-window due to an enhanced risk of hemorrhagic transformation which is thought to be caused by metalloproteinase (MMP). In experimental stroke inhibitors of the mitogen...
As compensation starts early after stroke, its neural plasticity mechanisms are probably normally facilitated by this interaction. In rodent models of stroke, the neural plasticity involved in learning to compensate with the non-paretic upper limb can compete with the neural plasticity related to ...